According to THE SAGE GROUP, There is a Significant Need for Innovative Endovascular Devices to Treat Below-the-Ankle (BTA) Disease in Critical Limb Ischemia (CLI) Patients

BEAUFORT, S.C.–(BUSINESS WIRE)– #CLIFighters–Research published by THE SAGE GROUP examines the prevalence, characteristics, comorbidities and consequences of BTA disease, as well as explores the challenges of endovascular revascularization. BTA disease is characterized by atherosclerotic stenoses and/or occlusions in one or more foot arteries. The pedal artery, plantar arteries (common, medial and lateral) and the plantar arch are among the foot arteries affected. “Although BTA disease is highly prevalent